New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
07:32 EDTXOMAXOMA downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded XOMA following the Phase II trial failure of gevokizumab in Erosive Osteoarthritis of the Hand.
News For XOMA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 6, 2015
07:26 EDTXOMACredit Suisse to hold a conference
Antibody Day 2015 to be held in New York on May 6.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use